Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

9480	Companies
185527	Keywords
117915	Articles
99372	Press releases

Home
Companies
Theranexus

BRIEF

published on 01/23/2025 at 18:05, 10 months 13 days ago

Theranexus Announces its Financial Agenda for 2025

Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
PRESS RELEASE

published on 01/23/2025 at 18:00, 10 months 13 days ago

THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025
Theranexus annonce son agenda financier pour l'année 2025, incluant les dates des publications des résultats financiers et de l'Assemblée Générale. Theranexus est une société biopharmaceutique spécialisée dans le traitement des maladies neurologiques rares

Euronext Growth Agenda Financier Theranexus Maladies Neurologiques Rares Annonces Dates
BRIEF

published on 01/16/2025 at 18:05, 10 months 20 days ago

Theranexus : Mise à jour mensuelle des droits de vote et actions

Droits De Vote Actions Biopharmaceutique Marché Boursier Theranexus
BRIEF

published on 01/16/2025 at 18:05, 10 months 20 days ago

Theranexus: Monthly update of voting rights and shares

Voting Rights Actions Stock Market Biopharmaceutical Theranexus
PRESS RELEASE

published on 01/16/2025 at 18:00, 10 months 20 days ago

Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital
Theranexus publie le nombre d'actions et de droits de vote au 31 décembre 2024, spécialisée dans le traitement des maladies neurologiques rares. Société cotée sur Euronext Growth à Paris

Droits De Vote Actions Euronext Growth Theranexus Neurologiques Rares
BRIEF

published on 01/09/2025 at 18:05, 10 months 27 days ago

Theranexus Publie sa Lettre Aux Actionnaires

Perspectives Financières Lettre Aux Actionnaires Theranexus Maladies Neurologiques Rares Plateforme Innovante
BRIEF

published on 01/09/2025 at 18:05, 10 months 27 days ago

Theranexus Publishes its Letter to Shareholders

Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform
PRESS RELEASE

published on 01/09/2025 at 18:00, 10 months 27 days ago

THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES
Theranexus annonce la publication de sa lettre aux actionnaires. La société biopharmaceutique spécialisée dans les maladies neurologiques rares invite à s'inscrire pour recevoir ses communications

Biopharmaceutique Communication Lettre Aux Actionnaires Theranexus Maladies Neurologiques Rares
PRESS RELEASE

published on 01/09/2025 at 18:00, 10 months 27 days ago

THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
Theranexus, an innovative biopharmaceutical company, announces the publication of its letter to shareholders. Shareholders can download the newsletter from the company website

Shareholders Biopharmaceutical Newsletter Theranexus Neurological Diseases
BRIEF

published on 12/17/2024 at 18:20, 11 months 19 days ago

Theranexus optimise sa trésorerie et prolonge son horizon financier

Financement Trésorerie Accord De Licence Theranexus Maladie De Batten

Accesswire

Published on 12/05/2025 at 18:45, 33 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 58 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 18 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 3 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 2 hours 18 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 20 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 52 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 3 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 26 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 32 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 7 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 7 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 20 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE